amikacin has been researched along with Cancer of Pancreas in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Campos, S; González-Castro, A; Pérez Canga, JL; Rodríguez-Borregán, JC | 1 |
Ambrose, J; Anant, S; Bye, BA; Eades, AE; Jack, JL; Manley, SJ; Messaggio, F; Olou, AA; Ruckert, MT; VanSaun, MN; Walsh, RM | 1 |
Akimoto, M; Koshikawa, N; Nagase, H; Takenaga, K | 1 |
Akimoto, M; Kawabata, Y; Maruyama, R; Tajima, Y; Takenaga, K | 1 |
4 other study(ies) available for amikacin and Cancer of Pancreas
Article | Year |
---|---|
Catheter-related bacteraemia caused by Raoultella ornithinolytica.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Catheter-Related Infections; Cefepime; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Female; Humans; Pancreatic Neoplasms; Postoperative Complications | 2018 |
Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells.
Topics: Adiponectin; Fatty Acids; Glycolysis; Humans; Pancreatic Neoplasms; Piperidines; Receptors, Adiponectin; Receptors, Artificial | 2022 |
Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice.
Topics: Animals; Cell Line, Tumor; Diet, High-Fat; Disease Models, Animal; Drug Resistance, Neoplasm; Humans; Male; Mice; Obesity; Pancreatic Neoplasms; Piperidines; Receptors, Adiponectin | 2021 |
Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis.
Topics: Apoptosis; Calcium; Calcium Channels; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Humans; Mitochondria; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Piperidines; Receptor-Interacting Protein Serine-Threonine Kinases; Receptors, Adiponectin; RNA Interference; RNA, Small Interfering; Signal Transduction; Superoxides | 2018 |